Drug name - Lexiscan
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6403567 | ASTELLAS | N-pyrazole A2A adenosine receptor agonists |
Apr, 2022
(5 months ago) | |
| US8106183 | ASTELLAS | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
Feb, 2027
(4 years from now) | |
| CN101379073A | ASTELLAS | Method For Preparing An A2A-Adenosine Receptor Agonist And Its Polymorphs |
Apr, 2013
(9 years ago) | |
| CN102260311A | ASTELLAS | Method For The Preparation Of A Type 2A Adenosine Receptor Agonist And Its Polymorphs Thing |
Mar, 2015
(7 years ago) | |
| CN1358191A | ASTELLAS | N-Pyrazole A |
Jun, 2020
(2 years ago) | |
| CN1167709C | ASTELLAS | N-Pyrazole A |
Jun, 2020
(2 years ago) | |
| EP1189916A2 | ASTELLAS | N-Pyrazole A 2A Receptor Agonists |
Jun, 2025
(2 years from now) | |
| EP1189916B1 | ASTELLAS | N-Pyrazole A 2A Receptor Agonists |
Jun, 2025
(2 years from now) | |
| EP1989214B1 | ASTELLAS | Process For Preparing An A2A-Adenosine Receptor Agonist And Its Polymorphs |
Feb, 2027
(4 years from now) | |
| EP1989214A1 | ASTELLAS | Process For Preparing An A2A-Adenosine Receptor Agonist And Its Polymorphs |
Feb, 2027
(4 years from now) | |
| EP1989214B8 | ASTELLAS | Process For Preparing An A2A-Adenosine Receptor Agonist And Its Polymorphs |
Feb, 2027
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE47301 | ASTELLAS | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
Feb, 2027
(4 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.4MG/5ML (0.08MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.